MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$37,138K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of investments
Share-based compensation expense
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss
Inventory, net
Purchases of investments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-44,741
-8,275
-40,371
-38,000
Depreciation
2,321
2,200
2,736
2,461
Amortization of intangible assets
1,020
1,020
1,019
368,429
Amortization of right-of-use assets
664
849
894
921
Amortization of patent license
516
-
-
-
Share-based compensation expense
9,263
4,459
9,588
10,984
Impairment charges
0
0
0
0
Merger-related compensation expense
-
-
0
-
Loss on extinguishment of debt
-
-
0
-
Gain on debt restructuring
-
-
0
-
Gain on disposal of assets
0
48,100
-
-
Accretion of discount on marketable securities, net
220
295
460
923
Change in the estimated fair value of contingent consideration
0
0
0
0
Inventory provision
1,363
54
-200
1,226
Deferred income taxes
0
0
0
0
Other
-225
-225
-232
-397
Accounts receivable, net
1,754
-6,098
4,832
-1,641
Inventory, net
11,261
3,206
-3,507
1,058
Prepaid expenses and other assets
-1,859
2,288
-717
-988
Accounts payable
5,478
-4,322
1,721
1,266
Accrued expenses
-2,077
314
4,554
1,011
Deferred revenue
-442
19
-584
-123
Operating lease liabilities
1,469
1,425
1,384
1,069
Contingent consideration liability
-
-
0
-
Other liabilities
734
5,132
1,026
-1,587
Net cash used in operating activities
-35,583
-44,691
-19,069
-18,707
Proceeds from disposal of assets
0
50,000
-
-
Payment for waiver of milestone obligation
0
1,900
-
-
Purchases of property and equipment
1,555
3,043
861
-86
Purchases of intangible assets
0
5,000
0
0
Cash paid for purchases of acquired entities, net of cash acquired
-
-
0
-
Purchase of patent license
2,056
-
-
-
Purchases of investments
5,099
52,448
33,094
65,825
Sales of investments
-
-
0
0
Maturities of investments
48,781
48,250
59,984
84,641
Net cash provided by investing activities
40,071
35,859
26,029
18,902
Proceeds from issuance of common stock under equity offerings, net of issuance costs
-
-
0
-
Proceeds from issuance of common stock from equity plans
255
1,437
0
1,469
Payment of debt issuance costs
-
-
0
-
Payment of contingent consideration
-
-
0
-
Payments made in conjunction with convertible notes exchange
-
-
0
-
Notes payable principal payoff
-
-
0
0
Net cash provided by financing activities
255
1,437
0
1,469
Net decrease in cash, cash equivalents, and restricted cash
4,743
-7,395
6,960
1,664
Cash, cash equivalents, and restricted cash at beginning of period
57,864
65,259
58,299
57,592
Cash, cash equivalents, and restricted cash at end of period
62,607
-
-
-
Cash and cash equivalents at end of period
61,003
-
-
-
Restricted cash at end of period
1,604
-
-
-
Cash, cash equivalents, and restricted cash at end of period
62,607
57,864
65,259
58,299
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of investments
$48,781K
(-75.04%↓ Y/Y)
Proceeds from issuance of
common stock from...
$255K
(-86.98%↓ Y/Y)
Net cash provided by
investing activities
$40,071K
(-43.18%↓ Y/Y)
Net cash provided by
financing activities
$255K
(-86.98%↓ Y/Y)
Canceled cashflow
$8,710K
Net decrease in
cash, cash...
$4,743K
(595.61%↑ Y/Y)
Canceled cashflow
$35,583K
Purchases of investments
$5,099K
(-95.68%↓ Y/Y)
Purchase of patent
license
$2,056K
Purchases of property and
equipment
$1,555K
(-19.80%↓ Y/Y)
Share-based compensation
expense
$9,263K
(-56.09%↓ Y/Y)
Accounts payable
$5,478K
(1184.75%↑ Y/Y)
Depreciation
$2,321K
(-70.21%↓ Y/Y)
Prepaid expenses and
other assets
-$1,859K
(72.70%↑ Y/Y)
Operating lease
liabilities
$1,469K
(184.91%↑ Y/Y)
Inventory provision
$1,363K
(-84.04%↓ Y/Y)
Amortization of intangible
assets
$1,020K
(-99.72%↓ Y/Y)
Other liabilities
$734K
(216.14%↑ Y/Y)
Amortization of right-of-use
assets
$664K
(-69.29%↓ Y/Y)
Amortization of patent
license
$516K
Other
-$225K
(78.75%↑ Y/Y)
Net cash used in
operating activities
-$35,583K
(51.54%↑ Y/Y)
Canceled cashflow
$24,912K
Net loss
-$44,741K
(90.44%↑ Y/Y)
Inventory, net
$11,261K
(191.13%↑ Y/Y)
Accrued expenses
-$2,077K
(13.71%↑ Y/Y)
Accounts receivable, net
$1,754K
(-62.94%↓ Y/Y)
Deferred revenue
-$442K
(-154.70%↓ Y/Y)
Accretion of discount on
marketable securities, net
$220K
(-92.62%↓ Y/Y)
Buy us a coffee
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)